Vanguard Group Inc Keros Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,957,109 shares of KROS stock, worth $20 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,957,109

Previous 1,856,418 5.42%

Holding current value

$20 Million

Previous $108 Million 71.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$15.64 - $70.0 $1.57 Million - $7.05 Million	100,691 Added 5.42%	1,957,109 $31 Million
Q3 2024 Nov 13, 2024	BUY	$41.68 - $58.07 $4.14 Million - $5.77 Million	99,298 Added 5.65%	1,856,418 $108 Million
Q2 2024 Aug 13, 2024	BUY	$44.58 - $66.89 $9.42 Million - $14.1 Million	211,362 Added 13.67%	1,757,120 $80.3 Million
Q1 2024 May 10, 2024	BUY	$41.26 - $70.48 $4.69 Million - $8 Million	113,563 Added 7.93%	1,545,758 $102 Million
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $698,719 - $1.06 Million	25,764 Added 1.83%	1,432,195 $56.9 Million
Q3 2023 Nov 14, 2023	BUY	$31.57 - $43.02 $7.03 Million - $9.58 Million	222,652 Added 18.81%	1,406,431 $44.8 Million
Q2 2023 Aug 14, 2023	BUY	$37.26 - $51.01 $5.06 Million - $6.92 Million	135,717 Added 12.95%	1,183,779 $47.6 Million
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $113,628 - $162,655	2,742 Added 0.26%	1,048,062 $44.8 Million
Q4 2022 Feb 10, 2023	BUY	$39.45 - $51.77 $5.47 Million - $7.18 Million	138,746 Added 15.3%	1,045,320 $50.2 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $3.75 Million - $5.41 Million	134,956 Added 17.49%	906,574 $34.1 Million
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $911,700 - $2.35 Million	35,025 Added 4.76%	771,618 $21.3 Million
Q1 2022 May 13, 2022	BUY	$42.12 - $59.36 $121,010 - $170,541	2,873 Added 0.39%	736,593 $40.1 Million
Q4 2021 Feb 14, 2022	BUY	$36.95 - $62.89 $885,285 - $1.51 Million	23,959 Added 3.38%	733,720 $42.9 Million
Q3 2021 Nov 12, 2021	BUY	$29.27 - $43.71 $1.22 Million - $1.82 Million	41,558 Added 6.22%	709,761 $28.1 Million
Q2 2021 Aug 13, 2021	BUY	$42.4 - $70.11 $28.3 Million - $46.8 Million	668,203 New	668,203 $28.4 Million

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.8M

Call Options Held

62.7K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $263M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Keros Therapeutics, Inc. Transaction History